# DESCRIPTION

## FIELD

- define field of invention

## INTRODUCTION

- motivate gene editing for muscle diseases

## SUMMARY

- introduce vector composition
- describe vector composition elements
- specify promoters and vectors
- outline composition embodiments
- describe cell and kit embodiments
- summarize methods of use

## DETAILED DESCRIPTION

- describe gene editing methods

### 1. Definitions

- define technical and scientific terms
- introduce open-ended transitional phrases
- define singular and plural references
- specify numeric ranges
- define "about" or "approximately"
- introduce adeno-associated virus (AAV)
- define allogeneic
- define amino acid
- define autologous
- introduce binding region
- define coding sequence
- define complement or complementary
- introduce control, reference level, and reference
- define correcting, gene editing, and restoring
- introduce clustered regularly interspaced short palindromic repeats (CRISPRs)
- define directional promoter
- introduce donor DNA, donor template, and repair template
- define Duchenne Muscular Dystrophy (DMD)
- define dystrophin
- define encapsulated
- define enhancer
- define genome editing
- define heterologous
- define homology-directed repair
- define identical or identity
- define mutant gene
- define non-homologous end joining pathway
- define normal gene
- define nuclease mediated NHEJ
- define nucleic acid
- define open reading frame
- define operably linked
- define partially-functional
- define peptide or polypeptide
- define premature stop codon
- define promoter
- define recombinant
- define sample
- define satellite cells
- define site-specific nuclease
- define stem cell
- define subject
- define substantially identical
- define target gene

### 2. Dystrophin Gene

- define dystrophin gene structure
- describe dystrophin gene mutations
- explain DMD disease characteristics
- introduce exon skipping therapy

### 3. CRISPR/Cas9-Based Gene Editing System

- introduce CRISPR/Cas9-based gene editing system
- describe Cas9 protein
- specify Cas9 protein sources
- explain Cas9 protein function
- describe PAM sequence recognition
- list PAM sequence examples
- describe Cas9 protein engineering
- introduce nuclear localization sequence
- describe mutant Cas9 molecules
- introduce VQR variant
- describe synthetic polynucleotides
- introduce Cas9 fusion protein
- describe fusion protein components
- specify second polypeptide domain activities
- list examples of second polypeptide domains
- describe linker design
- define nuclease activity
- describe nucleic acid association activity
- describe methylase activity
- describe demethylase activity
- introduce guide RNA (gRNA)
- describe gRNA structure
- describe gRNA targeting
- describe gRNA length and sequence
- introduce donor sequence
- describe donor sequence function
- describe gRNA and donor sequence ratio
- introduce repair pathways
- describe homology-directed repair (HDR)
- describe non-homologous end joining (NHEJ)

### 4. Genetic Constructs

- define genetic construct
- describe plasmid or expression vector
- detail CRISPR/Cas9-based gene editing system
- specify gRNA molecule encoding
- describe regulatory elements for gene expression
- detail initiation and termination codons
- describe promoter operably linked to CRISPR/Cas-based gene editing system
- specify enhancer upstream of CRISPR/Cas-based gene editing system
- describe mammalian origin of replication
- detail reporter gene and selectable marker

### 5. Pharmaceutical Compositions

- describe pharmaceutical composition formulation
- detail pharmaceutically acceptable excipient

### 6. Administration

- describe methods of introducing nucleic acid into host cell
- detail viral or bacteriophage infection
- describe transfection, conjugation, and protoplast fusion
- specify electroporation and nucleofection
- describe administration to subject

### 7. Kits

- describe kit for restoring function of dystrophin gene

### 8. Methods

- describe method of correcting mutant gene in cell

## 9. EXAMPLES

- present multiple examples of AAV-CRISPR gene editing in satellite cells

### Example 1

- describe plasmid design and AAV production
- describe animal models and AAV administration
- describe in vivo AAV administration and muscle analysis
- describe AAV-CRISPR cell transplantation experiments
- describe satellite cell isolation and genomic DNA analysis
- describe histology and immunofluorescence
- describe Western blots

### Example 2

- profile AAV serotypes for targeting efficiency of satellite cells
- compare AAV serotypes for transduction efficiency in satellite cells

### Example 3

- describe AAV9-CRISPR constructs targeting satellite cells for gene editing
- quantify gene editing outcomes in satellite cells

### Example 4

- compare recombination efficiency in satellite cells with muscle-specific promoters
- compare gene editing efficiencies in ubiquitous vs. muscle specific promoters

### Example 5

- demonstrate sustained dystrophin expression in AAV-CRISPR-treated muscle after serial injuries

### Example 6

- describe serial transplantation study
- detail CRISPR-Cas9 gene editing
- show dystrophin+ fibers in host TA muscles
- demonstrate long-term contribution of edited satellite cells
- quantify gene editing in satellite cells
- discuss importance of delivery methods
- provide general concept of invention
- define scope of invention
- incorporate references by citation
- list clauses for vector composition
- describe methods for correcting mutant genes
- outline methods for treating DMD

